Vimarsana
Biggest News Aggregation in the World

Nigel Key News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nigel Key. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nigel Key Today - Breaking & Trending Today

FDA Approves Hemgenix, First Gene Therapy to Treat Adults with Hemophilia B - Vimarsana News

FDA Approves Hemgenix, First Gene Therapy to Treat Adults with Hemophilia B

The U.S. Food and Drug Administration (FDA) approved Hemgenix (etranacogene dezaparvovec), gene therapy for the treatment of adults with hemophilia B (congenital factor 9 deficiency) who currently use factor 9 prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.

Infusing Hope for Hemophilia - Vimarsana News

Infusing Hope for Hemophilia

A gene therapy clinical trial for hemophilia shows promise and could be approved by the FDA later this year — a feat made possible, in part, by UNC-Chapel Hill's 70-year-old research program

Source: unc.edu
What we know about the super-rare blood clots linked to the J&J vaccine - Vimarsana News

What we know about the super-rare blood clots linked to the J&J vaccine

What we know about the super-rare blood clots linked to the J&J vaccine Experts are figuring out how to rapidly diagnose and treat the unusual clots linked to both the Johnson & Johnson and AstraZeneca shots. ByLinda Marsa Email Scientists are beginning to unravel what is sparking the rare but severe blood clotting reaction that has now been associated with both the Johnson & Johnson and the AstraZeneca coronavirus vaccines. Called cerebral venous sinus thrombosis (CVST), this condition occurs when clots form in veins that route blood from the brain, causing strokes or other brain damage. Yes...

Can AstraZeneca dispel doubts about its shots? - Vimarsana News

Can AstraZeneca dispel doubts about its shots?

Can AstraZeneca dispel doubts about its shots? With the company caught up in murky data releases and public relations misfires, experts worry that the world may turn its back on a vaccine that still holds promise for combating the pandemic. ByLinda Marsa The AstraZeneca shot was supposed to be the vaccine for a couple of billion people. It is inexpensive at just a couple of dollars per dose and can be stored in an ordinary fridge unlike the mRNA vaccines. But after reports the shot may trigger a rare side effect, and the company’s string of communication blunders, public health officials w...

USDA ERS - Persistent Cover Crop Adoption Varies by Primary Commodity Crop - Vimarsana News

USDA ERS - Persistent Cover Crop Adoption Varies by Primary Commodity Crop

Persistent Cover Crop Adoption Varies by Primary Commodity Crop The use of cover crops on U.S. cropland increased by 50 percent between 2012 and 2017. During this period, Federal and State conservation programs increased efforts to promote cover crops through financial and technical assistance. Cover crops—such as unharvested cereal rye, oats, winter wheat, or clover—are typically added to a crop rotation during the period in between two commodity or forage crops. Cover crops provide a living, seasonal coverage of soil that can result in a variety of on-farm benefits such as increased soi...

Source: usda.gov